TGFB1 and non-small cell lung carcinoma: In gefitinib-resistant NSCLC A549 (A549GR) cells, cRGDwV and cRGDyV suppressed cell growth and inhibited TGF-β1-induced mesenchymal marker expression, migration, and invasion.